Is Bright Minds Biosciences Inc (DRUG) Stock a Good Value Friday?

Bright Minds Biosciences Inc (DRUG) is near the bottom in its sector according to InvestorsObserver. DRUG gets an overall rating of 41. That means it scores higher than 41% of stocks. Bright Minds Biosciences Inc gets a 20 rank in the Healthcare sector. Healthcare is number 5 out of 11 sectors.

DRUG has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on DRUG!

See Full DRUG Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Bright Minds Biosciences Inc Stock Today?

Bright Minds Biosciences Inc (DRUG) stock is trading at $2.46 as of 10:32 AM on Friday, Aug 11, a loss of -$0.06, or -2.38% from the previous closing price of $2.52. The stock has traded between $2.46 and $2.62 so far today. Volume today is low. So far 103,632 shares have traded compared to average volume of 1,311,869 shares. Click Here to get the full Stock Report for Bright Minds Biosciences Inc stock.